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End stage kidney disease is associated with reduced exercise capacity, muscle atrophy and impaired 26 
muscle function. While these may be improved with exercise, single modalities of exercise do not 27 
traditionally elicit improvements across all required physiological domains. Blood flow restricted 28 
exercise may improve all of these physiological domains with low-intensities traditionally considered 29 
insufficient for these adaptions. Investigation of this technique appeals, but is yet to be evaluated in 30 
dialysis patients. Using a progressive crossover design, ten satellite haemodialysis patients underwent 31 
three exercise conditions over 2 weeks. Condition 1: 2 bouts (10min) of unrestricted cycling during 2 32 
consecutive haemodialysis sessions. Condition 2: 2 bouts of cycling with blood flow restriction while 33 
off-haemodialysis on 2 separate days. Condition 3: 2 bouts of cycling with blood flow restriction during 34 
2 haemodialysis sessions. Outcomes included haemodynamic responses (heart rate, blood pressure) 35 
throughout all sessions, participant-perceived exertion and discomfort on a Borg scale, and evaluation 36 
of ultrafiltration rates and Kt/V obtained post-hoc. Haemodynamic responses were consistent regardless 37 
of condition. Significant increases in heart rate, systolic blood pressure and mean arterial blood pressure 38 
(P<0.05) were observed post-exercise, followed by a reduction in blood pressures during the 60 min 39 
recovery (12 mmHg, 5 mmHg and 11 mm Hg for systolic, diastolic and mean arterial pressures, 40 
respectively). Blood pressures returned to pre-dialysis ranges following the recovery period. Blood flow 41 
restriction did not affect ultrafiltration achieved or Kt/V. Haemodynamic safety and tolerability of BFR 42 
during aerobic exercise on HD is comparable to standard aerobic exercise.  43 





End stage kidney disease (ESKD) is associated with reduced exercise capacity, skeletal muscle atrophy 45 
and impaired physical function (22). These deficiencies can be improved with aerobic and/or resistance 46 
exercise training performed during haemodialysis (HD) where low- to moderate-intensity exercise is 47 
considered safe and well-tolerated (6, 9, 20, 47, 49, 50). However, not all studies using traditional 48 
exercise, in particular aerobic exercise alone, result in marked improvements in muscle size, strength, 49 
exercise capacity, or physical function, and rarely are improvements observed across all of these 50 
physiological domains (18, 50). This is compounded by exercise not being widely adopted among 51 
patients with ESKD, with most patients displaying a significant reluctance to exercise (8, 28). Proposed 52 
exercise interventions therefore need to be safe, tolerable and at a minimum, similarly efficacious than 53 
the current alternatives. 54 
A viable option is blood flow restricted exercise (BFRE), which uses a pressurised tourniquet applied 55 
to the active limbs during exercise (14, 33). BFRE is known to enhance skeletal muscle strength and 56 
cross-sectional area more than equivalent-intensity non-blood flow restriction exercise, despite 57 
typically employing low exercise intensities (1, 15, 30, 34, 39, 46, 54). While aerobic exercise does not 58 
typically elicit gains in muscle size and strength, especially at the low volumes used in many exercise 59 
and dialysis studies (6, 27, 49, 50), aerobic BFRE continues to confer traditional adaptations of 60 
improved aerobic capacity and physical function, especially in deconditioned populations (10, 11, 46). 61 
Prominent theories suggest increased and preferential recruitment of type II muscle fibres as a result of 62 
localised compression-induced muscle hypoxia combined with greater metabolic stress of type I muscle 63 
fibres that are less resistant to hypoxia, as evidenced by examination of heat-shock proteins associated 64 
with skeletal muscle damage (12, 31, 55). Combined, this suggests multiple pathways may be 65 
responsible for the increased muscle strength and size following BFRE. This positions aerobic BFRE 66 
as an interesting prospect for patients with ESKD, as it can potentially elicit significant improvements 67 
across multiple physiological domains where traditional exercise generally has not among these patients 68 
(9, 18, 50). 69 




The applied cuff pressure during BFRE is typically high enough to occlude venous outflow from the 70 
muscles distal to the cuff at rest, but low enough to maintain arterial inflow (32). Capillary blood flow 71 
is generally proportional to venous blood flow (35). As venous blood flow is maintained during BFRE 72 
via the mechanical pump that occurs during muscular contractions, capillary blood flow is similarly 73 
maintained (25, 45, 48). Thus, under the proviso that the cuffs are only inflated during active periods 74 
of BFRE among dialysis patients, blood flow to all vascular beds should be largely maintained and not 75 
acutely affect dialysis adequacy (Kt/V) or the ultrafiltration rates (UF) of patients. 76 
Exercise induces acute changes to haemodynamics, in particular an elevation in systolic blood pressure 77 
(SBP) (43). This is sometimes, and more commonly in patients with ESKD, followed by significant 78 
post-exercise hypotension (PEH) (19). Both the SBP elevation and PEH are usually, but not exclusively 79 
self-resolving and largely asymptomatic (19, 43). This is of concern when programming exercise for 80 
patients with ESKD, as their haemodynamics are known to be unstable both during and following HD 81 
(17, 53). This instability is further complicated as patients with ESKD exhibit a high incidence of 82 
vascular disease (peripheral, cerebral, coronary) and other cardiovascular diseases (3). Symptomatic 83 
intradialytic hypotension (IDH) is of particular concern due to the relationship between IDH and 84 
vascular access thrombosis, inadequate dialysing, and mortality (17). Thus, while exercise is considered 85 
safe to perform intradialytically, it requires vigilant monitoring of the haemodynamic responses and 86 
careful patient selection. 87 
The magnitude of the haemodynamic response to BFRE with resistance training is typically greater than 88 
for equivalent-intensity non-BFRE (38). However, this response is markedly lower for aerobic BFRE 89 
such as cycle ergometer exercise when compared with BFRE with resistance training (36). Notably, 90 
this reduced haemodynamic response was also lower than with low-intensity traditional resistance 91 
exercise, regarded as safe for patients with ESKD (36, 50, 51). However, BFRE has not been evaluated 92 
in patients with moderate to advanced chronic kidney disease or ESKD either intradialytically or off-93 
dialysis. 94 




Therefore, the aim of this study was to evaluate the acute haemodynamic responses (heart rate and blood 95 
pressure) as well as the perceived tolerability (required effort and discomfort) to aerobic BFRE under 96 
progressively increased haemodynamically unstable environments among patients with ESKD. 97 
Materials and Methods 98 
Study Design 99 
This study utilised a progressive crossover design. Ten participants (Table 1) underwent six supervised 100 
cycling exercise sessions over a fifteen-day period aligning with each participant’s regular dialysis 101 
schedule. The study was conducted according to the Declaration of Helsinki (2013) and ethics approval 102 
was granted under a collaborative research agreement by both the Eastern Health Human Research 103 
Ethics Committee and the Deakin University Human Research Ethics Committee. 104 
 105 
Participants 106 
Participants (n = 7 male; n = 3 female; Table 1) were recruited through promotion in participating 107 
dialysis clinics and asked to voluntarily participate in the study. Prospective participants were screened 108 
initially by assessing their medical history against the inclusion and exclusion criteria of the study and 109 
consulted face-to-face by a member of the research team regarding any personal or undocumented 110 
physical limitations. Following this, approval to participate was obtained from the treating physician. 111 
Participants were required to provide written, informed consent prior to participation in the study. 112 
 113 
Inclusion and Exclusion criteria 114 
Eligible participants were male or female, over 18 years of age, diagnosed with ESKD (stage V chronic 115 
kidney disease; glomerular filtration rate <15 mL.min-1.1.73m-2), and having undertaking HD for a 116 
minimum of 12 weeks. Participants were excluded if they engaged in regular physical activity or sport 117 
(>150 min.wk-1), or structured resistance training (> 1 session.wk-1); if they had persistent uncontrolled 118 




blood pressure, clinically significant or symptomatic cardiovascular or peripheral vascular disease, or 119 
any musculoskeletal limitations or neurological conditions; if they were current smokers; or if they had 120 
required hospitalisation for non-dialysis reasons in the 4 weeks prior to the study. Participants were also 121 
deemed unable to exercise during individual sessions if they were over their dialysis base weight by 122 
more than 5%, indicating fluid overload, and reduced cardiovascular reserve; if SBP was greater than 123 
180 mmHg or less than 90 mmHg prior to commencing exercise, indicating markedly unstable blood 124 
pressure. This did not include the very first blood pressure reading during HD, as this is known to be 125 
highly variable (2). 126 
 127 
Sample Size Calculation 128 
There was no existing data from which to inform a sample size calculation looking at a difference in 129 
SBP response to exercise with blood flow restriction and non-blood flow restriction cycling exercise 130 
among patients with ESKD. As such, sample size calculations were made based on previous data 131 
showing the change in SBP for standard, non-blood flow restriction cycling exercise among dialysis 132 
patients (19, 42). This suggested that 8 participants would provide sufficient power (0.8) to derive 133 
significance for a 30% change in SBP immediately following exercise. 134 
 135 
Exercise training 136 
Participants were examined under three ‘conditions’, with each comprising exercise sessions on two 137 
days, separated by one day (Figure 1). The order of conditions was the same for each participant. 138 
Condition 1 was non-BFRE while ‘on’ HD (noBFRE-HD), to represent a ‘baseline’ response for 139 
intradialytic exercise when participants are considered to be at their most haemodynamically unstable 140 
while undergoing HD (44). Condition 2 was BFRE while ‘off-dialysis’ (BFRE-noHD) to evaluate 141 
BFRE, which may cause heightened haemodynamic responses, when participants are more 142 
haemodynamically stable, without the influence of HD (38, 44). Condition 3 was BFRE while ‘on’ HD 143 
(BFRE-HD), which examined the potentially more haemodynamically demanding BFRE while patients 144 




were also exposed to greater haemodynamic instability during HD (44). Data were also obtained post-145 
hoc from the 4 dialysis runs preceding these exercise sessions to represent a usual care, non-exercising 146 
HD control (CON-HD). 147 
For exercising conditions conducted on HD, participants underwent exercise during the first 2 hours of 148 
HD (21, 41). All sessions were monitored by an accredited exercise physiologist as part of the research 149 
team. On each day, cycling was completed on an electronically braked cycle ergometer (LODE 150 
Excalibur 911905, Lode B. V., Groningen, The Netherlands) positioned to the side of each participant’s 151 
dialysis bed allowing them to remain seated on their bed, rotated such that their legs could reach the 152 
pedals from behind the cycle ergometer. This was always to the same side as the dialysis machine, to 153 
allow participants to have their fistula arm supported and avoid access lines from moving excessively 154 
during the active portions of the exercise session. 155 
All cycling sessions followed the same structure (Figure 2). Each session included an unloaded 5-156 
minute cycling warm up and cool down, at a participant-selected cadence. The main component of the 157 
exercise session consisted of two 10-minute bouts of cycling separated by a 20-minute rest period. The 158 
prescribed volume and intensity reflected a balance between entry-level, multiple bout blood flow 159 
restriction protocols and traditional aerobic training components from other HD studies (20, 23, 40). 160 
Workload for each 10-minute bout was between 10 W and 30 W, equivalent to a low-to-moderate rating 161 
of perceived effort (RPE) (5). RPE was provided by participants during the final 30 seconds of each 162 
exercise bout (13, 18, 52). Patient workloads remained constant across all conditions.  163 
 164 
Blood Flow Restriction 165 
For conditions that required blood flow restriction, the restriction was applied during each exercise bout 166 
only, using an automatic tourniquet system (A.T.S 3000, Zimmer Inc., OH, USA) connected to 167 
pneumatically inflated cuffs positioned around the proximal end of the thigh. Measurement of limb 168 
occlusion pressure (LOP) was completed prior to each blood flow restriction exercise session. This was 169 
done on each lower limb using digital plethysmography (Pulse Sensor, Zimmer ATS 3000, Zimmer 170 




Inc., OH, USA) applied to the second toe. The cuffs were inflated until the plethysmograph no longer 171 
detected blood flow (total limb occlusion). This pressure was recorded as LOP. During exercise sessions 172 
cuffs were inflated to 50% LOP, typical of training interventions that produce increased skeletal muscle 173 
size and strength without the undue neuromuscular or mechanical fatigue often observed with restriction 174 
pressures >50% LOP (16, 29, 46). By utilising a restriction pressure individualised to the level of LOP, 175 
this accounts for peripheral vascular differences between participants resulting in an equivalent degree 176 
of blood flow restriction. 177 
 178 
Measurements 179 
Heart Rate and Blood Pressure 180 
For all sessions, haemodynamic measures were taken at baseline, immediately prior to, and immediately 181 
following each exercise bout (Figure 2). Haemodynamic measures included HR, SBP, DBP and MAP. 182 
In addition, haemodynamic measures were taken at 20-minute intervals until 60 minutes post exercise 183 
(Figure 2). HR, SBP, DBP and MAP were measured using the dialysis machines (4008S NG, Fresenius 184 
Medical Care Australia Pty Ltd, Milsons Point, New South Wales). These dialysis machines took 185 
approximately 30 seconds to take the desired measures, so post-exercise measures (‘End-bout 1’ and 186 
‘End-bout 2’) are within the first 30 seconds following completion of each exercise bout. 187 
In addition, measurements of end-HD SBP and DBP were retrieved post-hoc from stored hospital 188 
records by a nephrologist from the treating organisation, as these data are collected routinely by renal 189 
nurses at the completion of each HD session. Similarly, HR, SBP, DBP and MAP data were retrieved 190 
for the 4 sessions preceding the beginning of the trial to act as baseline, non-exercising HD control 191 
values for each of these variables (only baseline/pre-dialysis, and hourly thereafter including end-HD). 192 
These data were not available for the BFRE-noHD condition. 193 
 194 




Ultrafiltration Rate and Dialysis Adequacy 195 
Ultrafiltration rate (UF) and dialysis adequacy (Kt/V) data were obtained post-hoc from patient records. 196 
This data included both the prescribed UF and actual nett UF achieved, as well as the Kt/V recorded 197 
from the dialysis machines. These data were not available for the BFRE-noHD condition.  198 
 199 
Perceptual Measures 200 
In the final 30 seconds of each of the main exercise bouts, participants were asked to provide a rating 201 
of perceived exertion (RPE) on a Borg scale ranging from 6 (no exertion) to 20 (maximal exertion) (5) 202 
and a rating of perceived discomfort (RPD) using a modified Borg scale ranging from 0 (no discomfort) 203 
to 10 (maximal discomfort) (4). As a standard precaution, all participants were monitored for, or asked 204 
to report, chest pain/discomfort, dyspnoea, lower limb pain, symptoms of severe hyper- or hypotension, 205 
and other signs of adverse events. 206 
 207 
Statistical Analysis 208 
All statistical analyses were performed using SPSS 25.0 (IBM Corp, Chicago IL, United States of 209 
America). Continuous variables were compared using a mixed model analysis of variance (ANOVA) 210 
using within factors (time, session), and between factors (condition) for which significance was set at 211 
an α level < 0.05.  212 
If there was no statistical difference between the two sessions within each condition (noBFRE-HD, 213 
BFRE-noHD, BFRE-HD, CON-HD), the mean data for each condition was subsequently analysed, 214 
allowing for a direct comparison of conditions. To achieve this, comparisons between each condition 215 
for all continuous variables was made with a mixed model ANOVA using within factors (time), and 216 
between factors (condition). Mauchly’s test for sphericity was used to assess equality of variance, and 217 
if violated a Greenhouse-Geisser correction was applied. A significant α level of less than 0.05 was 218 
adopted for all statistical tests. All outcome data are presented as means ± SEM unless stated. The 219 




differences between prescribed UF and nett UF achieved, as well as the dialysis machine Kt/V were 220 




Haemodynamic Measures 225 
There was a main effect for time for HR (F8, 216 = 76.09, P < 0.001), SBP (F8, 216 = 52.81, P < 0.001), 226 
DBP (F8, 216 = 17.44, P < 0.001), and MAP (F8, 216 = 37.47, P < 0.001), such that they increased with 227 
exercise and returned to baseline following the 60-minute recovery period (Figure 3). In addition, there 228 
was a mild post-exercise hypotension evident for all conditions over the first 60 min of recovery when 229 
compared with baseline (P < 0.001). The lowest recovery measures for SBP, DBP and MAP were 12 230 
(3) mmHg, 5 (1) mmHg, and 11 (2) mmHg lower than baseline, respectively (P < 0.001). There was no 231 
main effect for condition or interaction between time and condition in any of the haemodynamic 232 
measures. Similarly, there were no significant differences between any exercising groups and CON-HD 233 
for any haemodynamic measures immediately before HD or at the completion of HD. 234 
 235 
Ultrafiltration Rate and Dialysis Adequacy 236 
Results for both UF and dialysis adequacy are presented in Table 2. There was no significant difference 237 
between the prescribed UF for any of the dialysis conditions, including non-exercising dialysis sessions 238 
for which data was obtained post-hoc (F2,27 = 0.15, P = 0.86). Similarly, there was no significant 239 
difference between any of the dialysis conditions for the difference between prescribed UF and nett UF 240 
achieved (F2,27 = 0.58, P = 0.57). The dialysis machine-based Kt/V was also not different for any of the 241 
dialysis conditions (F2,24 = 0.63, P = 0.54). 242 
 243 




Perceptual Measures 244 
There was a main effect for exercise bout for RPE (F1, 27 = 21, P < 0.001) and RPD (F1, 27 = 11.88, P = 245 
0.002), as well as a main effect for condition for RPE (F2, 27 = 3.43, P = 0.047) and RPD (F2, 27 = 33.33, 246 
P < 0.001) (Figure 4). However, there was no interaction for bout and condition for either RPE (F2, 27 = 247 
0.859, ns), or RPD (F2, 27 = 2.14, P = 0.14). Specifically, RPE was significantly higher following 248 
exercise bout 2 [16 (0)] than following exercise bout 1 [14 (0)] (P < 0.001). RPE was also significantly 249 
lower for noBFRE-HD [13 (1)] than for both BFRE-noHD [16 (1)] (P = 0.027) and BFRE-HD [16 (1)] 250 
(P = 0.01), with no significant difference between BFRE-noHD and BFRE-HD. RPD was significantly 251 
higher following exercise bout 2 [13 (0)] than following exercise bout 1 [12 (0)] (P = 0.002). RPD was 252 
also significantly lower for noBFRE-HD [9 (1)] than for both BFRE-noHD [15 (1)] and BFRE-HD [15 253 
(1)] (P < 0.001), with no significant difference between BFRE-noHD and BFRE-HD. 254 
 255 
Adverse Events 256 
One case of exercise-related syncope occurred with BFRE-HD (blood pressure 88/68). Ultrafiltration 257 
was stopped, and a saline bolus administered. No prolonged effects of the adverse event occurred, and 258 
the participant chose to remain enrolled in the study. One additional instance of a participant feeling 259 
‘light-headed’ in recovery was reported (blood pressure 85/56), during which ultrafiltration was stopped 260 
briefly. However, this was self-resolving, and ultrafiltration resumed within five minutes. 261 
Despite both of these instances of symptomatic IDH occurring following BFRE-HD, which may imply 262 
a temporal association with that condition, both participants also presented with fluid overload and 263 
subsequent abnormally high prescribed UFs on these days relative to each patients norm. However, the 264 
excess pre-dialysis weight was not outside the limits defined in the exclusion criteria for this study, so 265 
exercise proceeded. Each of these patients also completed another BFRE-HD session without issue. 266 
Regardless, a tighter limit for how much fluid overload prior to an HD session precludes participation 267 
in exercise may be useful in future research (for example 3% above base-weight). Additionally, constant 268 
monitoring of haemodynamic variables is necessary to ensure that these adverse events are captured. 269 




One participant also suffered mid-fistula bruising when repositioning themselves on their dialysis chair 270 
following an exercise session. This was not a result of the exercise intervention itself but occurred 271 
during a session and warranted reporting. 272 
 273 
Discussion 274 
This present study demonstrates the novel application of blood flow restriction aerobic exercise for 275 
patients with ESKD on dialysis. The major finding was that haemodynamic responses (HR, SBP, DBP, 276 
and MAP) are not significantly different immediately following intradialytic aerobic BFRE (BFRE-277 
HD) compared with either aerobic BFRE off-dialysis (BFRE-noHD), or to intradialytic aerobic non-278 
BFRE (noBFRE-HD). Following exercise all blood pressure measures (SBP, DBP, MAP) were 279 
significantly lower compared with pre-exercise levels across all conditions, which continued through 280 
the first 60-minutes of recovery. This is similar to post-exercise blood pressure reductions observed 281 
previously among studies examining time-course changes in blood pressure with intradialytic aerobic 282 
exercise (19, 26, 43). However, in the present study the haemodynamic responses were not significantly 283 
different between exercising conditions, nor when compared to a usual care HD session (CON-HD). 284 
Therefore, responses to BFRE can be considered similar to what would typically be expected from 285 
traditional intradialytic aerobic exercise, and not devoid from usual care HD. It is important to note that 286 
the present study was powered to assess changes in SBP in response to exercise and, due to the lack of 287 
prior data examining BFRE among dialysis patients, the study may not be powered to detect the 288 
differences between conditions. 289 
The US National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative guidelines define 290 
IDH as a decrease in SBP ≥ 20 mmHg or MAP ≥ 10 mmHg with accompanying symptoms (17). 291 
However, the potency of various IDH definitions suggest that absolute thresholds of SBP < 90 mmHg 292 
for those with pre-HD SBP < 160 mmHg, and SBP < 100 for those with pre-HD SBP > 160 mmHg 293 
display more robust associations with mortality (17). In the present study there were only two occasions 294 
where such readings were accompanied by symptoms of hypotension, both of which we report as 295 




adverse events, and each specifically aligned with abnormally high relative prescribed UF for each 296 
patient. However, the overall mean data from the present study indicates that neither the fall in systolic 297 
blood pressure or mean arterial pressure, nor the lowest absolute mean values for blood pressure 298 
measurements were representative of IDH. In addition, blood pressure data collected post-hoc from 299 
dialysis records suggested that all blood pressure measures returned to pre-exercise levels after the 300 
recovery period and prior to the conclusion of HD (Figure 3). When comparing the time-course changes 301 
in blood pressure measures across the HD sessions including exercise with the usual care HD data 302 
retrieved post-hoc, it appears that the mild overall reduction in blood pressure across the duration of 303 
HD was commonplace. Thus, the observed down-trend in blood pressure of HD sessions may be 304 
attributable to fluid removal during the treatment itself. Indeed, the instances of symptomatic IDH were 305 
similar in the present study between exercising HD runs and usual care HD runs, with 2 episodes of 306 
IDH occurring among 40 intradialytic exercise sessions and 3 episodes of IDH occurring among the 307 
data from 40 usual care HD sessions collected post-hoc. 308 
Alongside haemodynamic responses to BFRE, it is equally important to ensure that BFRE does not 309 
impact the efficacy of the HD treatment itself. In the present study the differential between prescribed 310 
UF and nett UF achieved was no different following any of the intradialytic exercise conditions 311 
compared with the same patients’ usual care HD sessions. This was also true for the dialysis machine 312 
Kt/V values, which were no different during exercising HD sessions compared with usual care HD 313 
sessions, and all also exceeded recommended UF targets of 1.4 per HD session (24). This suggests that 314 
blood flow is sufficiently maintained during BFRE to ensure that the process of ultrafiltration was 315 
maintained, likely mediated by the mechanical pump facilitated by repeated muscular contractions 316 
during exercise (i.e. skeletal muscle pump). 317 
The absence of any main effects for condition across all haemodynamic measures in the present study 318 
suggests that neither the application of blood flow restriction to the exercise, nor whether exercise was 319 
completed ‘on’ or ‘off’ HD significantly affected the response. Similarly, that none of the exercising 320 
conditions required modifications to UF nor affected dialysis adequacy (Kt/V), is a positive indicator 321 
that utilising BFRE intradialytically does not impede the treatment fundamentally required by patients 322 




undergoing HD. Therefore, it does not appear that aerobic BFRE should be considered any less suitable 323 
from a haemodynamic perspective compared with traditional exercise regimens recommended for 324 
patients with ESKD. Undertaken chronically, BFRE may in fact be preferable if it can provide greater 325 
enhancement to muscle size, strength and physical function among patients with ESKD, although this 326 
requires further research. 327 
The perceptual responses during both BFRE conditions were significantly higher than the non-BFRE 328 
condition. However, both perceived effort and perceived discomfort were still lower than common 329 
perceptual responses to moderate-to-high intensity non-BFRE with resistance training, which is 330 
considered a safe mode of exercise in this population (7, 37, 50). Furthermore, previous studies have 331 
highlighted that perception of effort and discomfort with BFRE subsides with repeated use of the 332 
technique, approaching that of equivalent non-BFRE (10, 36). With such a reduction in perceptual 333 
responses following repeated use of BFRE, it seems unlikely that BFRE would dissuade participation 334 
in a training program or adversely affect exercise adherence beyond what is already seen among patients 335 
with ESKD. 336 
 337 
Recommendations and Clinical Implications 338 
Future studies utilising this exercise modality would benefit from a simpler, and more practical exercise 339 
equipment set up, whereby participants can remain in their normal seated position during HD. This may 340 
involve the use of commercial pedal sets which are able to be fitted to the dialysis chair, or customised 341 
cycle ergometers that can be positioned in front of the dialysis chair more easily. This may also reduce 342 
some patient discomfort caused by a lack of postural support in the present study. 343 
Additionally, although diabetes is the most frequent underlying comorbidity among ESKD, only two 344 
participants in the present study had diabetes. As there is potential for blood flow restriction to elicit a 345 
metabolic response, future studies utilising BFRE among dialysis patients could provide additional 346 
insight by examining blood glucose and lactate responses. 347 




Given the established capabilities for chronic BFRE training to increase muscle size, strength and 348 
physical function over a non-blood flow restriction equivalent among other populations (10, 46), it has 349 
the potential to be a valuable adjunct to essential medical treatment among populations such as patients 350 
with ESKD who are contraindicated to or unlikely to participate in exercise of sufficient intensity to 351 
achieve these beneficial musculoskeletal adaptations. 352 
Conclusion 353 
The present study supports the notion that blood flow restriction aerobic exercise is a tolerable and 354 
viable alternative mode of exercise for patients with ESKD. While perceived to be more challenging, 355 
the haemodynamic response to blood flow restriction aerobic exercise suggests that there is no greater 356 
cardiovascular stress than equivalent aerobic exercise without blood flow restriction. Similarly, the 357 
technique did not appear to have any detrimental effect on the adequacy of the HD treatment itself. 358 
Therefore, our demonstration of the haemodynamic response and tolerability of blood flow restriction 359 
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Table 1. Participant characteristics.515 
Age (years) 61 ± 13 
HD Vintage (years) 5.6 ± 3.7 
Base weight (kg) 68.23 ± 15.51 
Resting brachial SBP (mmHg) 137 ± 14 
Limb Occlusion Pressure (mmHg) 223 ± 17 











• Polycystic Kidney Disease 
• Asthma 

















• Haemoglobin (g/L) 
• Potassium () 
• URR (%) 
• Phosphate (mmol/L) 
• Albumin (g/L) 
• Parathyroid Hormone (pmol/L) 
 
 
111.2 ± 10.9 
5.2 ± 0.6 
75.2  ± 5.5 
1.9  ± 0.6 
33.4  ± 4.5 
64.2  ± 35.0 
 
Exercise load (W) 21 ± 6 
 516 
Data are mean ± SD; Abbreviations: HD – Haemodialysis; SBP - Systolic blood pressure; BFRE – 517 
Blood flow restricted exercise. 518 




Table 2. Mean values by condition (during haemodialysis only) for the prescribed ultrafiltration rate, 520 
nett ultrafiltration rate achieved, the difference between the prescribed and the nett achieved 521 








(prescribed – nett) 
(ml∙kg-1∙h-1) 
Kt/V 
CON-HD 6.18 ± 0.81 5.53 ± 0.84 0.65 ± 0.34 1.6 ± 0.06 
noBFRE-HD 5.53 ± 0.84 5.27 ± 0.79 0.26 ± 0.18 1.53 ± 0.08 
BFRE-HD 6.02 ± 0.93 5.6 ± 0.86 0.42 ± 0.22 1.51 ± 0.06 
 523 
Data are mean ± SD; Abbreviations: UF – Ultrafiltration rate; Kt/V – value for dialysis adequacy; 524 
CON-HD – non-exercising usual care haemodialysis; noBFRE-HD – non-blood flow restricted exercise 525 
performed during haemodialysis; BFRE-HD – blood flow restricted exercise performed during dialysis. 526 




Figure Legends 528 
 529 
530 
Figure 1: Study design. Timing of exercise sessions. Abbreviations: noBFRE-HD – Non-blood flow 531 
restriction intradialytic cycling; BFRE-noHD – Blood flow restriction cycling off-haemodialysis; 532 
BFRE-HD – Blood flow restriction intradialytic cycling; Shaded blocks indicate non-dialysis day. 533 
 534 
 535 
Figure 2: Single session timeline. Timing of measures indicated on the single session timeline. 536 
Abbreviations: LOP – Limb occlusion pressure; HR – Heart rate; SBP – Systolic Blood pressure; DBP 537 
– Diastolic Blood pressure; MAP – Mean arterial pressure; RPE – rating of perceived exertion; RPD 538 





Figure 3: Haemodynamic responses to both blood flow restriction, and non-blood flow restriction 541 
exercise among patients on dialysis. Figures representative of changes in a) Heart rate, b) Systolic 542 
blood pressure, c) Diastolic blood pressure, and d) Mean arterial pressure. # = significantly different to 543 





Figure 4: Perceptual responses to both blood flow restriction, and non-blood flow restriction 546 
exercise among patients on dialysis. Figures representative of a) rating of perceived exertion, and b) 547 
rating of perceived discomfort immediately following each exercise bout within a session. # = Exercise 548 
bout 2 significantly different from bout 1 (P < 0.001). 549 
